Avania acquires Spanish medical technology CRO Anagram to expand its CRO offering in a new region of Europe

BY Valeed Khan
October 10, 2024
0 Comments
169 Views
Read in 3 Minutes

With its comprehensive suite of customizable solutions, Avania leads the industry by delivering targeted, actionable medical device and diagnostics strategies in every major market worldwide.

BILTHOVEN, Netherlands-Avania , the global medical technology contract research organization (CRO) and consulting services partner, today announced the acquisition of Anagram . Headquartered in Barcelona, Spain, Anagram is a leading MedTech CRO in the Iberian Peninsula, providing MedTech solutions to clients in Spain, the broader European market and beyond.

Founded in 1998, Anagram offers a comprehensive CRO model to its clients, including central laboratory services for diagnostic imaging (centralized quality control and centralized image review in clinical trials). It focuses on the therapeutic areas of cardiology, oncology and neurology. It has studies in the United States, the United Kingdom, Spain, the Netherlands, France, Germany, and other countries.

Anagram is a perfect fit for Avania, allowing the company to expand its CRO operations in Spain and providing greater access to a country experiencing rapid growth in the MedTech space. This acquisition will enhance cross-selling opportunities by increasing the scale of the company and will remove reliance on current outsourcing partners. Avania’s clients will benefit from geographic expansion and a greater number of experts specialized in key therapeutic areas.

“ The addition of Anagram solidifies our vision to become a trusted global partner for the MedTech community, advancing innovations from bench to bedside and improving the quality of life for patients worldwide,” said Jason Monteleone , President and CEO of Avania. “ This will allow us to gain a significant presence in Spain and Southern Europe, while strengthening our cardiovascular and neurological franchises and expanding our oncology resources.”

About Avania

Avania is the leading global clinical research organization and MedTech advisory partner focused on medical devices, diagnostics/IVD, and digital health. Core offerings include comprehensive clinical research outsourcing, market access, reimbursement, regulatory, and product development consulting services. Avania’s goal is to be your trusted global partner to advance your medical technology from innovation to commercialization to improve patient health and well-being. To advance your medical technology, you need Avania.

About Anagram

Anagram is a Clinical Research Organization (CRO) based in Spain that provides high-level services in clinical development and post-authorization testing for drugs and medical devices. Services include core lab, analysis and reporting by highly experienced professionals. Anagram has specialized expertise in cardiology, neurology and oncology.

The text of the press release resulting from a translation should in no way be considered official. The only version of the press release that is authoritative is that of the press release in its original language. The translation must always be compared with the source text, which will constitute precedent.